Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy.

Wang QZ, Xu W, Habib N, Xu R.

Curr Cancer Drug Targets. 2009 Jun;9(4):572-94. Review.

PMID:
19519323
2.

MicroRNAs as biomarkers and therapeutic drugs in human cancer.

Osaki M, Takeshita F, Ochiya T.

Biomarkers. 2008 Nov;13(7):658-70. doi: 10.1080/13547500802646572 . Review.

PMID:
19096960
3.

MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.

Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P.

Curr Med Chem. 2009;16(9):1047-61. Review.

PMID:
19275611
4.

MicroRNAs: small but potent oncogenes or tumor suppressors.

Lee YS, Dutta A.

Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Review.

PMID:
16784027
5.

Role of miRNA in carcinogenesis and biomarker selection: a methodological view.

Ahmed FE.

Expert Rev Mol Diagn. 2007 Sep;7(5):569-603. Review.

PMID:
17892365
6.

MicroRNAs and prostate cancer.

Pang Y, Young CY, Yuan H.

Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):363-9. Review.

7.
8.

MicroRNA function in cancer: oncogene or a tumor suppressor?

Shenouda SK, Alahari SK.

Cancer Metastasis Rev. 2009 Dec;28(3-4):369-78. doi: 10.1007/s10555-009-9188-5. Review.

PMID:
20012925
9.

MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.

Shi M, Guo N.

Cancer Treat Rev. 2009 Jun;35(4):328-34. doi: 10.1016/j.ctrv.2008.12.002. Epub 2009 Jan 25. Review.

PMID:
19171434
10.

MicroRNAs and cancer: past, present, and potential future.

Nelson KM, Weiss GJ.

Mol Cancer Ther. 2008 Dec;7(12):3655-60. doi: 10.1158/1535-7163.MCT-08-0586. Review.

11.

MicroRNAs and cancer.

Cowland JB, Hother C, Grønbaek K.

APMIS. 2007 Oct;115(10):1090-106. Review.

PMID:
18042145
12.

miRNA: the new gene silencer.

Ross JS, Carlson JA, Brock G.

Am J Clin Pathol. 2007 Nov;128(5):830-6. Review.

14.

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG.

Cancer Res. 2009 Jul 15;69(14):5776-83. doi: 10.1158/0008-5472.CAN-09-0587. Epub 2009 Jul 7.

15.

New insight into the role of miRNAs in leukemia.

Zhang H, Chen Y.

Sci China C Life Sci. 2009 Mar;52(3):224-31. doi: 10.1007/s11427-009-0036-1. Epub 2009 Mar 18. Review.

PMID:
19294347
16.

[MicroRNAs in diagnosis and prognosis in lung cancer].

Avila-Moreno F, Urrea F, Ortiz-Quintero B.

Rev Invest Clin. 2011 Sep-Oct;63(5):516-35. Review. Spanish.

PMID:
22468482
17.

The utility of LNA in microRNA-based cancer diagnostics and therapeutics.

Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S.

Semin Cancer Biol. 2008 Apr;18(2):89-102. doi: 10.1016/j.semcancer.2008.01.004. Epub 2008 Jan 15. Review.

PMID:
18295505
18.

Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells.

Lee EM, Shin S, Cha HJ, Yoon Y, Bae S, Jung JH, Lee SM, Lee SJ, Park IC, Jin YW, An S.

Int J Mol Med. 2009 Jul;24(1):45-50.

PMID:
19513533
19.

MicroRNA involvement in the pathogenesis and management of breast cancer.

Khoshnaw SM, Green AR, Powe DG, Ellis IO.

J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. Review.

PMID:
19398594
20.

MicroRNAs: novel biomarkers for human cancer.

Bartels CL, Tsongalis GJ.

Clin Chem. 2009 Apr;55(4):623-31. doi: 10.1373/clinchem.2008.112805. Epub 2009 Feb 26. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk